© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 17, 1382-1397,
September 1, 1993
© 1993 Oxford University Press
AIDS-Related Malignancies: the Emerging Epidemic
Alexandra M. Levine, M.D., University of Southern California School of Medicine, Norris Cancer Center, 1441 Eastlake Ave., Rm. 801, Los Angeles, CA 90033.
The incidence of three malignancies has increased in conjunction with the epidemic of human immunodeficiency virus (HIV) disease, and they are currently considered acquired immunodeficiency syndrome (AIDS)-defining conditions. These are Kaposi's sarcoma, associated with AIDS since the onset of the epidemic in 1981; intermediate or high-grade B-cell lymphoma, which became AIDS-defining in 1985; and cervical carcinoma in HIV-infected women, formally recognized as an AIDS-defining diagnosis on January 1, 1993. Approximately 40% of all patients with AIDS have developed cancer during the course of HIV infection. Further, as survival has improved in HIV disease, the incidence of these malignancies has increased. It is thus expected that greater numbers of patients with AIDS-related lymphoma and cervical cancer will be diagnosed in the years ahead. The epidemiologic factors associated with neoplastic disease differ among patients with the three AIDS-related malignancies. The pathogenesis of neoplastic disease also differs. The specific etiologic steps in the development of AIDS-related Kapos's sarcoma and lymphoma are currently unknown. However, a great deal of information has already been acquired, which may have bearing on the pathogenesis of malignant disease in general, as well as the elucidation of future therapeutic modalities. The specific epidemiologic, etiologic, and clinical characteristics of the AIDS-related malignancies will be described herein. It is hoped that this review will serve to outline our current understanding of this area, to introduce the questions and controversies which are apparent in the field, and to mention those areas in which future research might be focused. [J Natl Cancer Inst 85: 1382–1397, 1993]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Cocco, C. Bellan, R. Tussiwand, D. Corti, E. Traggiai, S. Lazzi, S. Mannucci, L. Bronz, N. Palummo, C. Ginanneschi, et al. CD34+ Cord Blood Cell-Transplanted Rag2-/- {gamma}c-/- Mice as a Model for Epstein-Barr Virus Infection Am. J. Pathol., November 1, 2008; 173(5): 1369 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Capello, M. Martini, A. Gloghini, M. Cerri, S. Rasi, C. Deambrogi, D. Rossi, M. Spina, U. Tirelli, L. M. Larocca, et al. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis Haematologica, August 1, 2008; 93(8): 1178 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gloghini, G. Gaidano, L. M. Larocca, F. Pierconti, A. Cingolani, L. Dal Maso, D. Capello, S. Franceschi, U. Tirelli, M. Libra, et al. Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Am. J. Pathol., July 1, 2002; 161(1): 163 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Otieno, C. Banura, E. Katongole-Mbidde, J. L. Johnson, M. Ghannoum, A. Dowlati, R. Renne, E. Arts, C. Whalen, M. M. Lederman, et al. Therapeutic Challenges of AIDS-Related Non-Hodgkin's Lymphoma in the United States and East Africa J Natl Cancer Inst, May 15, 2002; 94(10): 718 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Little, M. Gutierrez, E. S. Jaffe, A. Pau, M. Horne, and W. Wilson HIV-Associated Non-Hodgkin Lymphoma: Incidence, Presentation, and Prognosis JAMA, April 11, 2001; 285(14): 1880 - 1885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Carbone, A. Gloghini, L. M. Larocca, D. Capello, F. Pierconti, V. Canzonieri, U. Tirelli, R. Dalla-Favera, and G. Gaidano Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas Blood, February 1, 2001; 97(3): 744 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Caselli, C. Klersy, M. de Martino, C. Gabiano, L. Galli, P. A. Tovo, and M. Arico Human Immunodeficiency Virus-Related Cancer in Children: Incidence and Treatment Outcome--Report of the Italian Register J. Clin. Oncol., November 15, 2000; 18(22): 3854 - 3861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Pedersen and L. Hoffman-Goetz Exercise and the Immune System: Regulation, Integration, and Adaptation Physiol Rev, July 1, 2000; 80(3): 1055 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al. The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells Blood, August 1, 1998; 92(3): 1011 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Coppola, A. Veronesi, S. Indraccolo, F. Calderazzo, M. Mion, S. Minuzzo, G. Esposito, D. Mauro, B. Silvestri, P. Gallo, et al. Lymphoproliferative Disease in Human Peripheral Blood Mononuclear Cell-Injected SCID Mice. IV. Differential Activation of Human Th1 and Th2 Lymphocytes and Influence of the Atopic Status on Lymphoma Development J. Immunol., March 1, 1998; 160(5): 2514 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moses, J. Nelson, and G. C. Bagby Jr The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis Blood, March 1, 1998; 91(5): 1479 - 1495. [Full Text] [PDF]
|
|
|
|
|
|
A. Carbone, G. Gaidano, A. Gloghini, L. M. Larocca, D. Capello, V. Canzonieri, A. Antinori, U. Tirelli, B. Falini, and R. Dalla-Favera Differential Expression of BCL-6, CD138/Syndecan-1, and Epstein-Barr Virus-Encoded Latent Membrane Protein-1 Identifies Distinct Histogenetic Subsets of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas Blood, February 1, 1998; 91(3): 747 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ometto, C. Menin, S. Masiero, L. Bonaldi, A. Del Mistro, A. M. Cattelan, E. D'Andrea, A. De Rossi, and L. Chieco-Bianchi Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas Blood, July 1, 1997; 90(1): 313 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. i Tortajada, J. A. Martinez-Climent, J. A. Lopez-Andreu, and J. G. i Castell Pediatricians and Cancer Prevention Arch Pediatr Adolesc Med, February 1, 1997; 151(2): 209 - 209. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Cesarman, Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles Kaposi's Sarcoma-Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity-Based Lymphomas N. Engl. J. Med., May 4, 1995; 332(18): 1186 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ficarra and L.E. Eversole HIV-Related Tumors of the Oral Cavity Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(2): 159 - 185. [Abstract] [Full Text] [PDF]
|
|